Current and Future Treatments for Diabetic Retinopathy

Francine Behar-Cohen; Anat Loewenstein

doi:10.3390/pharmaceutics14040812

Pharmaceutics (Apr 2022)

Current and Future Treatments for Diabetic Retinopathy

Francine Behar-Cohen,
Anat Loewenstein

Affiliations

Francine Behar-Cohen: Centre de Recherche des Cordeliers, Université de Paris, 75006 Paris, France
Anat Loewenstein: Division of Ophthalmology, Tel-Aviv Sourasky Medical Center, Tel Aviv-Yafo 6423906, Israel

DOI: https://doi.org/10.3390/pharmaceutics14040812
Journal volume & issue: Vol. 14, no. 4
p. 812

Abstract

Read online

The pathogenesis of diabetic retinopathy in humans remains imperfectly understood; in particular, the kinetics of the various pathogenic events in the very early stages of retinal damage are difficult to recognize [...]

n/a

Published in Pharmaceutics

ISSN: 1999-4923 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Pharmacy and materia medica
Website: http://www.mdpi.com/journal/pharmaceutics/

About the journal

Abstract

Keywords